METHODS

Case definitions
The case definitions used are those established by the Ministère de la Santé et des Services sociaux de Québec and correspond with those recommended by the Public Health Agency of Canada: 8, 10 A confirmed case includes:
• Clinical evidence of invasive disease with laboratory confirmation of infection through isolation of N. meningitidis from a normally sterile site (blood, cerebrospinal fluid, joint, pleural or pericardial fluid) A probable case includes: • Clinical evidence of invasive disease including meningitis and/or septicaemia with purpura fulminans or petechiae, OR • Clinical evidence of invasive disease AND detection of N. meningitidis antigen in the cerebrospinal fluid.
To be counted as a case in Montréal, patients must have been residents of and must have become ill in Montréal or have become ill elsewhere and have been transferred to Montréal.
To measure sensitivity, we compared data on confirmed and probable IMD cases among Montréal residents between April 1, 1995 and December 31, 2008 using two independent data sources: the reportable disease database (RDD) and the provincial hospitalization database (Maintenance et exploitation des données pour l'étude de la clientèle hospitalière or MED-ECHO). We extracted hospitalizations using ICD-9 (036.0-036. 9; used 1995-2005) and ICD-10 (A39.0-39. 9, used 2006-2008) codes associated with IMD. This assumed that all IMD cases are hospitalized. The sensitivity of case reporting was calculated using the cases reported to the RDD (R) divided by the total estimated cases by a capture-recapture calculation (N). 11 As MED-ECHO records are non-nominal, the datasets were linked manually by age, sex and a three-day window between the dates of reporting and dates of admission. For the unmatched MED-ECHO entries, an epidemiologist reviewed hospital and laboratory records against the case definition.
The timeliness for reporting by physicians and laboratories was calculated as the difference in days between the date of specimen collection (signifying physician contact) and the date of reporting. A 7-day limit was deemed to be a realistic period during which PEP can be administered within the 14-day period in which it is most effective, accounting for delays in reaching household contacts. 12 The space-time scan statistic (STSS) was used to detect cluster signals for January 1, 1992 cal significance of occurring not due to chance (p<0.05). A cluster was defined as two or more serogroup B or C cases bound too tightly in time (≤40 days between the date of specimen collection for the first and last case, or four times the longest incubation period) and geographic location (cluster area included ≤50% of the Montréal population) to be produced by chance. Cluster signals were tested retrospectively. When a cluster was detected retrospectively, we applied repeated prospective scans. Prospective scans simulated the addition of cases over time in order to evaluate the generation of early warning signals resulting from the addition of each successive case. The delay between the first early warning signal and the date of each subsequent case was calculated to estimate how early the cluster was detected. These results were compared with observations of clustering found in case files. As a program evaluation, this protocol did not require ethical review.
RESULTS
The date of specimen collection was present for 168 (91.3%) of the 184 cases retrieved from the RDD (R) for 1995 to 2008. There were 147 hospitalizations retrieved from MED-ECHO (S) ( Table 1) . A total of 133 cases were found in both datasets (C), 51 in RDD only (N 1 ) and 14 in MED-ECHO only. Investigation of the 14 unmatched hospitalizations found 8 true cases (N 2 ) and 6 false-positive cases. Three of the eight true cases met the confirmed case definition and were supported by laboratory confirmation, and five of the eight could not be retrieved without a date of birth and were considered confirmed without laboratory confirmation. Of the six false-positive hospitalizations, three of the six were unrelated meningitis (not N. meningitidis), two of the six had a change in discharge diagnosis and one of the six had a coding error. Therefore, we adjusted the number of MED-ECHO hospitalizations from 147 to 141 (147 minus 6 false-positive cases). Capture-recapture estimated 195 total cases. The sensitivity was 94.3% [95% CI 90. .
Of the 184 reported cases, 100 (54.3%) and 168 (91.3%) were reported by physicians and laboratories, respectively. Of the 168 cases with a date of specimen collection, 87 (51.8%) were reported within seven days by physicians (range 0 to 13 days) and 115 (68.5%) were reported within seven days by laboratories (range 0 to 39 days) (Figure 2 ). Overall, 155 (92.3%) cases were reported within seven days by the first reporting source. Physicians tended to report a higher proportion of cases within days zero to two (40.5%), which is reflected in two thirds of all cases being reported by the first reporter by day two (66.7%). From days three to seven, laboratories reported a consistently higher proportion of cases (50.6% to 68.5%) compared to physicians (45.8% to 51.8%).
For the 206 cases from 1992 to 2008, 2 of the 11 clusters detected were statistically significant. Four clustered serogroup C cases were reported between December 9, 1993 and January 5, 1994 (RR=81.1, p<0.04). Although two deaths occurred in a short time span, the case files did not indicate that this cluster was detected or investigated in real time and no microbiological subtyping information was available to explore its plausibility. Prospective detection signalled the cluster when the second case was added on CANADIAN JOURNAL OF PUBLIC HEALTH • JULY/AUGUST 2013 e337
Cumulative 13 Prospective detection signalled the cluster when the second case was added on October 7, and again with each successive case, reducing detection time by 8-13 days. From the case files and the published outbreak report, we were unable to identify the date that the cluster was manually detected.
DISCUSSION
Case-reporting sensitivity remained high with 94.3% of cases reported to the surveillance system, similar to the 1993-1995 capture-recapture estimate for Montréal (94.8%). 9 The overall timeliness of reporting was inadequate. The proportion (54%) of physician reports was low; 46% of cases were dependent on timeinsensitive laboratory reporting, which tended to increase slowly after the first two days. To compare, physicians reported 70% of cases in Montréal in 1993-1995. 9 The proportion of physicians reporting cases compares negatively to that of a comparably sized population in Thames Valley, UK (90%).
14 This may affect the ability of the public health department to administer PEP and vaccination to contacts in the 14-day window. A total of 92.3% of cases were notified by physicians or laboratories within seven days, meaning that in theory, 13 cases were not notified in time to conduct thorough contact tracing and offer PEP when indicated. Correcting these avoidable delays may prevent such secondary cases as have been recently documented in the UK and the US. 15, 16 Without specific mention of IMD, a previous survey on the knowledge of notifiable diseases reporting among emergency physicians in Canada showed substantial barriers concerning knowledge on which diseases to report to the public health department and the time and effort required to report. 17 However, as a severe disease that affects children which can be notified on a clinical basis before any laboratory confirmation, it follows that physician reporting is likely to be more assured for IMD as compared to other reportable diseases. 18 In this case, reporting appears to have shifted to laboratories. Therefore, ad-hoc reminders to physicians and the posting of reportable disease lists and guidelines for reporting procedures in emergency rooms may be useful. 17 For laboratories, automated electronic reporting of results using an online system would be ideal for increasing speed. However, this will require accommodating the various types of software used in laboratories and hospitals, which is currently not feasible.
Space-time scan statistics detected cluster signals at the local level in 1994 and 1995. One cluster signal was shown to have evidence of being microbiologically-linked through identical microbiological profiles, and the prospective method identified an emerging outbreak linked to a risk group ("ravers"). 13 This provided early warning of a suspected cluster before the serotyping that traditionally confirms an outbreak after cumulative cases is undertaken. No cluster signals were generated after 1995. The decreased incidence since 2001 may have lowered the power to detect clustering, thus limiting usefulness in a low incidence period. As well, the proportion of fulminant cases to asymptomatic carriers involved in clusters may be low. Only 4.4% (9/206) cases were found to be clustered. Similarly, only 4.2% of cases were found to be clustered using STSS with molecular typing in Germany. 19 At the local level, STSS may be more effective in detecting clusters of high-incidence diseases such as shigellosis as compared to meningococcal disease. 20 There are several limitations to this evaluation. The data sources may not be completely independent because the public health department and hospitals may exchange information on cases; this may overestimate the reporting completeness. 21 The under-reporting of the 51 cases found in the RDD but not listed in MED-ECHO could not be further investigated due to lack of identifying data in the MED-ECHO dataset, but may indicate several possibilities: that infection by N. meningitidis may have been coded as another bacterial or viral cause of meningitis in MED-ECHO; for fatal cases, that N. meningitidis may not have been isolated by the time of completion of the discharge form; and that some fulminant cases may have been reached by public health but not hospitalized due to rapid recovery or death. 21, 22 To fully explore these possibilities, registries that contain unique identifiers to perfectly match cases and hospitalizations would be optimal for routine evaluations, such as that used in Denmark. 23 Second, the true impact of the reduced physician reporting is dependent on whether physicians undertook preventive actions such as administering PEP and vaccinating contacts (who are often family members to whom they have access). Third, cluster detection sensitivity was decreased by the inability to incorporate asymptomatic carriers and geographic locators other than residence where transmission often occurs (i.e., day cares, workplaces).
Our findings suggest that vigilance towards IMD reporting has shifted from physicians to laboratories in this era of declining incidence in Montréal. This may be true for other jurisdictions in Canada. We recommended three improvements for the surveillance system: 1) reminding physicians to report probable and confirmed cases in order to provide simultaneous reporting by two sources, 2) restating the role of the public health department in more extensive contact tracing beyond family members, and 3) in the absence of automatic electronic reporting, monitoring and increasing the speed of laboratory reporting. When incidence is high, daily cluster analysis by serogroup may hasten the detection of outbreaks by one to two weeks, adding to a public health practitioner's initial "hunch" of an outbreak before serotyping is available. Such early warning systems require, as does routine surveillance, complete and timely reporting by clinicians.
RÉSUMÉ OBJECTIF :
Bien qu'elles soient rares à Montréal, les infections invasives à méningocoques continuent de causer de la morbidité grave et de la mortalité. En période d'incidence décroissante, notre objectif était d'évaluer la sensibilité et la rapidité de la déclaration des cas et la capacité de détecter statistiquement les cas groupés de cette maladie.
MÉTHODE :
Nous avons utilisé la base de données des maladies à déclaration obligatoire de la Direction de santé publique (« RDD ») pour calculer la rapidité de la déclaration des cas par les médecins et laboratoires pour la période de 1995 à 2008. La sensibilité de la déclaration des cas a été évaluée par la méthode capture-recapture en utilisant le « RDD » et la base de données des départs hospitaliers (« MED-ECHO »). Pour évaluer la détection des cas groupés dans le temps et l'espace, nous avons appliqué une statistique d'agrégation spatio-temporelle au « RDD » avec les cas codés pour la date et la localisation géographique, pour la période de 1992 à 2008.
RÉSULTATS :
Bien que la sensibilité du système ait été considérée élevée, à 94 %, les médecins ont déclaré seulement 54 % des cas; 92.3 % des cas ont été déclarés par les médecins ou laboratoires en sept jours ou moins. Cela signifie que, en théorie, 13 cas n'ont pas été déclarés à temps pour faire l'enquête épidémiologique et offrir la chimioprophylaxie aux contacts étroits. Dans les années où l'incidence était élevée, les statistiques d'agrégation spatio-temporelle ont détecté deux agrégats significatifs de cas une à deux semaines plus tôt que la détection traditionnelle par la surveillance manuelle des cas accumulés.
CONCLUSION :
Pour améliorer le fonctionnement du système, nous recommandons de mettre l'accent sur la déclaration par les laboratoires et le renforcement de la déclaration rapide par les médecins. Si l'incidence augmente, nous recommandons d'utiliser des statistiques d'agrégation spatio-temporelle pour identifier les cas groupés, ce qui peut constituer un système de détection précoce d'une éclosion émergente pour les praticiens de santé publique. 
